Maria Huang, MD, FAAP WCAAP | Vaccine Committee Co-Chair
New Maternal & Infant RSV Immunization Updates for 2026-27 Resp Season
The American College of Obstetricians and Gynecologists (ACOG) has extended the maternal RSV vaccination window through March 1 (instead of January 31) for the 2026-27 respiratory season
- Eligibility Window: Pregnant individuals can receive a single dose of the bivalent RSV vaccine Abrysvo from September 1 through March 1.
- Gestational Timing: Recommended for administration at 32 through 36 weeks of pregnancy during RSV season.
AAP Expands 2nd season RSV immunization recommendations
- AAP expands RSV prophylaxis to select 8-19 mo children entering 2nd season.
- Eligible: CHD, neuromuscular/lung disease, Down syndrome, certain chromosomal disorders.
- Includes CF, recent-support CLD, born <32 wks, and Native American/Alaska Native children.
- 2nd dose recommended regardless of maternal RSV vaccine or 1st-season immunization.
- 1st-season priority remains: nirsevimab or clesrovimab unless maternal RSV vaccine given
Resources:
